+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986094
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Vascular Graft Market size was estimated at USD 3.51 billion in 2023, USD 3.77 billion in 2024, and is expected to grow at a CAGR of 7.39% to reach USD 5.79 billion by 2030.

A vascular graft is a surgical process that redirects blood flow around a blocked or partially blocked artery in the heart by using a blood vessel taken from another part of your body, also known as a graft. Vascular grafts can be made from various materials, including synthetic polymers, such as polytetrafluoroethylene (PTFE) and polyurethane, and biological materials, such as collagen and human or animal tissue. The rise in the prevalence of vascular disorders and the rise in the geriatric population prone to cardiovascular diseases increases the adoption of vascular grafts. However, the risk of complications post-implantation of a vascular graft, such as graft infection and blood clots, may further hinder the adoption of the vascular graft. Nevertheless, the rise of biomaterial research for developing advanced, biocompatible grafts and the ongoing advancements in vascular imaging technologies such as 3D angiography offer potential for significant growth opportunities for the market.

Regional Insights

The vascular graft market is evolving in the Americas owing to technological advancements, rising healthcare expenditure, and the prevalence of cardiovascular disorders and diabetes in the region. Strong focus on regulatory compliance and safety measures, substantial research and development projects, increasing awareness regarding vascular grafts, and growing healthcare infrastructure encourage using vascular graft procedures to improve treatment outcomes in the EMEA region. Growing prevalence of lifestyle diseases and the accelerating expansion of healthcare services, significant medical technology advancements are resulting in the development of enhanced vascular graft procedures in the APAC region. Besides, the development of bioengineered vascular grafts that mimic the natural blood vessel structure and composition is anticipated to increase the use of this medical procedure by health professionals to treat various medical conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vascular Graft Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vascular Graft Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V.

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Raw Material
    • Biological Materials
      • Human Saphenous & Umbilical Veins
      • Tissue Engineered Materials
    • Polyester
    • Polytetrafluoroethylene
    • Polyurethane
  • Product
    • Coronary Artery By-Pass Graft
    • Endovascular Stent Graft
    • Hemodialysis Access Graft
    • Peripheral Vascular Graft
  • Application
    • Aneurysm
    • Cardiovascular
    • Diabetes
    • Kidney Failure
    • Vascular Occlusion
  • End-User
    • Ambulatory Surgical Center
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Vascular Graft Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vascular Graft Market?
  3. What are the technology trends and regulatory frameworks in the Vascular Graft Market?
  4. What is the market share of the leading vendors in the Vascular Graft Market?
  5. Which modes and strategic moves are suitable for entering the Vascular Graft Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Vascular Graft Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
5.1.1.2. Growing preference for minimally invasive procedures
5.1.1.3. Rising number of clinical trials of vascular grafts
5.1.2. Restraints
5.1.2.1. High treatment cost of vascular graft procedures
5.1.3. Opportunities
5.1.3.1. Improvements in the design and performance of vascular grafts
5.1.3.2. Development of tissue-engineered vascular grafts
5.1.4. Challenges
5.1.4.1. Infections associated with vascular grafts
5.2. Market Segmentation Analysis
5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Vascular Graft Market, by Raw Material
6.1. Introduction
6.2. Biological Materials
6.3.1. Human Saphenous & Umbilical Veins
6.3.2. Tissue Engineered Materials
6.3. Polyester
6.4. Polytetrafluoroethylene
6.5. Polyurethane
7. Vascular Graft Market, by Product
7.1. Introduction
7.2. Coronary Artery By-Pass Graft
7.3. Endovascular Stent Graft
7.4. Hemodialysis Access Graft
7.5. Peripheral Vascular Graft
8. Vascular Graft Market, by Application
8.1. Introduction
8.2. Aneurysm
8.3. Cardiovascular
8.4. Diabetes
8.5. Kidney Failure
8.6. Vascular Occlusion
9. Vascular Graft Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital
10. Americas Vascular Graft Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vascular Graft Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Vascular Graft Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
13.3.2. Investment & Funding
13.3.2.1. Xeltis’ aXess Vascular Graft Development Receives Funding From European Innovation Council
13.3.3. Award, Recognition, & Expansion
13.3.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Affluent Medical
14.1.3. B. Braun Melsungen AG
14.1.4. Becton, Dickinson and Company
14.1.5. BIOVIC Sdn. Bhd.
14.1.6. Boston Scientific Corporation
14.1.7. Cardinal Health Inc.
14.1.8. Cook Medical, Inc.
14.1.9. Corcym S.r.l.
14.1.10. CryoLife, Inc.
14.1.11. Endologix Inc.
14.1.12. Getinge AB
14.1.13. Heart Medical Europe B.V.
14.1.14. Japan Lifeline Co., Ltd.
14.1.15. Lemaitre Vascular, Inc.
14.1.16. Medtronic PLC
14.1.17. Merit Medical Systems, Inc.
14.1.18. Perouse Medical SAS by Vygon SAS
14.1.19. Rua Life Sciences PLC
14.1.20. Shanghai Suokang Medical Implants Co. Ltd.
14.1.21. Terumo Corporation
14.1.22. Vascular Graft Solutions Ltd.
14.1.23. VUP Medical
14.1.24. W. L. Gore & Associates, Inc.
14.1.25. Xeltis B.V.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
FIGURE 3. VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VASCULAR GRAFT MARKET DYNAMICS
FIGURE 7. VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
FIGURE 8. VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 6. VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 8. VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 45. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 71. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 72. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 76. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 77. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 86. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 132. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 142. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 162. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 163. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 182. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 183. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. POLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 187. QATAR VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 188. QATAR VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. QATAR VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 222. TURKEY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 237. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. VASCULAR GRAFT MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym S.r.l.
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe B.V.
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Perouse Medical SAS by Vygon SAS
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • W. L. Gore & Associates, Inc.
  • Xeltis B.V.

Methodology

Loading
LOADING...

Table Information